MEN1 and acute myeloid leukemia: DS-1594b is an oral menin inhibitor which showed preclinical activity through promoting differentiation and reducing serial colony forming capabilities in cell lines and patient derived xenograft models of KMT2A-r and NPM1mut AML [17].